Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Paolo Anderlini
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Chemicals & Drugs
Concepts & Ideas
Physiology
Phenomena
Sign-in to see full Profile
Network (preview)
61
Giralt, Sergio
44
Champlin, Richard
39
Champlin, Richard
32
Hosing, Chitra
32
Khouri, Issa
31
Körbling, Martin
28
Przepiorka, Donna
25
Ueno, Naoto
24
De Lima, Marcos
24
Donato, Michele
22
Couriel, Daniel
22
Gajewski, James
22
Andersson, Borje
22
Khouri, Issa
21
Saliba, Rima
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Paolo Anderlini (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Anderlini Paolo
Donors, donors, and more donors.
Blood 2009;114(18):3721-2.
-
2009: Pulsipher Michael A; Chitphakdithai Pintip; Logan Brent R; Leitman Susan F; Anderlini Paolo; Klein John P; Horowitz Mary M; Miller John P; King Roberta J; Confer Dennis L
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose.
Blood 2009;114(13):2606-16.
-
2009: Popat Uday; Saliba Rima; Thandi Rupinderjit; Hosing Chitra; Qazilbash Muzaffar; Anderlini Paolo; Shpall Elizabeth; McMannis John; Körbling Martin; Alousi Amin; Andersson Borje; Nieto Yago; Kebriaei Partow; Khouri Issa; de Lima Marcos; Weber Donna; Thomas Sheeba; Wang Michael; Jones Roy; Champlin Richard; Giralt Sergio
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):718-23.
-
2009: Hosing Chitra; Saliba Rima M; Ahlawat Sheena; Körbling Martin; Kebriaei Partow; Alousi Amin; De Lima Marcos; Okoroji Julia-Grace; McMannis John; Qazilbash Muzaffar; Anderlini Paolo; Giralt Sergio; Champlin Richard E; Khouri Issa; Popat Uday
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.
American journal of hematology 2009;84(6):335-7.
-
2009: Pulsipher Michael A; Chitphakdithai Pintip; Miller John P; Logan Brent R; King Roberta J; Rizzo J Douglas; Leitman Susan F; Anderlini Paolo; Haagenson Michael D; Kurian Seira; Klein John P; Horowitz Mary M; Confer Dennis L
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program.
Blood 2009;113(15):3604-11.
-
2009: Tam Constantine S; Bassett Roland; Ledesma Celina; Korbling Martin; Alousi Amin; Hosing Chitra; Kebraei Partow; Harrell Robyn; Rondon Gabriela; Giralt Sergio A; Anderlini Paolo; Popat Uday; Pro Barbara; Samuels Barry; Hagemeister Frederick; Medeiros L Jeffrey; Champlin Richard E; Khouri Issa F
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
Blood 2009;113(18):4144-52.
-
2009: Devetten Marcel P; Hari Parameswaran N; Carreras Jeanette; Logan Brent R; van Besien Koen; Bredeson Christopher N; Freytes César O; Gale Robert Peter; Gibson John; Giralt Sergio A; Goldstein Steven C; Gupta Vikas; Marks David I; Maziarz Richard T; Vose Julie M; Lazarus Hillard M; Anderlini Paolo
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1):109-17.
-
2009: Anderlini Paolo
Effects and safety of granulocyte colony-stimulating factor in healthy volunteers.
Current opinion in hematology 2009;16(1):35-40.
-
2009: Champlin Richard; de Lima Marcos; Kebriaei Partow; Rondon Gabriela; Fisher Tobi; Jabbour Elias; Cortés Jorge E; Kantarjian Hagop; Anderlini Paolo; Alousi Amin; Hosing Chitra; Shpall Elizabeth; Popat Uday; Qazilbash Muzaffar; Andersson Borje; Giralt Sergio
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.
Clinical lymphoma & myeloma 2009;9 Suppl 3():S261-5.
-
2008: Qazilbash Muzaffar H; Saliba Rima M; Nieto Yago; Parikh Gaurav; Pelosini Matteo; Khan Fatima B; Jones Roy B; Hosing Chitra; Mendoza Floralyn; Weber Donna M; Wang Michael; Popat Uday; Alousi Amin; Anderlini Paolo; Champlin Richard E; Giralt Sergio
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(12):1401-7.
-
2008: Peggs Karl S; Anderlini Paolo; Sureda Anna
Allogeneic transplantation for Hodgkin lymphoma.
British journal of haematology 2008;143(4):468-80.
-
2008: McCullough Jeffrey; Kahn Jeffrey; Adamson John; Anderlini Paolo; Benjamin Richard; Confer Dennis; Eapen Mary; Hirsch Betsy; Kuter David; Lazarus Ellen; Pamphilon Derwood; Stroncek David; Sugarman Jeremy; Wilson Robert
Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues.
Transfusion 2008;48(9):2008-25.
-
2008: Alousi Amin M; Saliba Rima M; Okoroji Grace-Julia; Macapinlac Homer A; Hosing Chitra; Korbling Martin; Samuels Barry I; Popat Uday; Kebriaei Partow; Anderlini Paolo; Qazilbash Muzaffar H; de Lima Marcos; Giralt Sergio A; Champlin Richard E; Khouri Issa F
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.
British journal of haematology 2008;142(5):786-92.
-
2008: Rhodes Beverly; Anderlini Paolo
Allogeneic peripheral blood stem cell collection as of 2008.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2008;38(3):219-27.
-
2008: Khouri Issa F; McLaughlin Peter; Saliba Rima M; Hosing Chitra; Korbling Martin; Lee Ming S; Medeiros L Jeffrey; Fayad Luis; Samaniego Felipe; Alousi Amin; Anderlini Paolo; Couriel Daniel; de Lima Marcos; Giralt Sergio; Neelapu Sattva S; Ueno Naoto T; Samuels Barry I; Hagemeister Fredrick; Kwak Larry W; Champlin Richard E
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
Blood 2008;111(12):5530-6.
-
2008: Hosing C; Saliba R M; Okoroji G-J; Popat U; Couriel D; Ali T; De Padua Silva L; Kebriaei P; Alousi A; De Lima M; Qazilbash M; Anderlini P; Giralt S; Champlin R E; Khouri I
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(6):1166-71.
-
2008: Anderlini Paolo; Swanston Nancy; Rashid Ashif; Bueso-Ramos Carlos; Macapinlac Homer A; Champlin Richard E
Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(4):478-80.
-
2008: Anderlini Paolo; Saliba Rima; Acholonu Sandra; Giralt Sergio A; Andersson Borje; Ueno Naoto T; Hosing Chitra; Khouri Issa F; Couriel Daniel; de Lima Marcos; Qazilbash Muzaffar H; Pro Barbara; Romaguera Jorge; Fayad Luis; Hagemeister Frederick; Younes Anas; Munsell Mark F; Champlin Richard E
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.
Haematologica 2008;93(2):257-64.
-
2008: Anderlini Paolo; Champlin Richard E
Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges.
Blood 2008;111(4):1767-72.
-
2008: de Lima M; Champlin R E; Thall P F; Wang X; Martin T G; Cook J D; McCormick G; Qazilbash M; Kebriaei P; Couriel D; Shpall E J; Khouri I; Anderlini P; Hosing C; Chan K W; Andersson B S; Patah P A; Caldera Z; Jabbour E; Giralt S
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(2):258-64.
-
2007: Oran B; Giralt S; Couriel D; Hosing C; Shpall E J; de Meis E; Khouri I F; Qazilbash M; Anderlini P; Kebriaei P; Popat U; Carrasco-Yalan A; Champlin R E; de Lima M
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(12):2540-4.
-
2007: Kebriaei Partow; Detry Michelle A; Giralt Sergio; Carrasco-Yalan Antonio; Anagnostopoulos Athanasios; Couriel Daniel; Khouri Issa F; Anderlini Paolo; Hosing Chitra; Alousi Amin; Champlin Richard E; de Lima Marcos
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.
Blood 2007;110(9):3456-62.
-
2007: Qazilbash Muzaffar H; Saliba Rima M; Ahmed Bilal; Parikh Gaurav; Mendoza Floralyn; Ashraf Noman; Hosing Chitra; Flosser Thuy; Weber Donna M; Wang Michael; Couriel Daniel R; Popat Uday; Kebriaei Partow; Alousi Amin M; Anderlini Paolo; Naeem Rizwan C; Champlin Richard E; Giralt Sergio A
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1066-72.
-
2007: Jabbour E; Rondon G; Anderlini P; Giralt S A; Couriel D R; Champlin R E; Khouri I F
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation.
Bone marrow transplantation 2007;40(5):431-5.
-
2007: Ozdemir E; Saliba R M; Champlin R E; Couriel D R; Giralt S A; de Lima M; Khouri I F; Hosing C; Kornblau S M; Anderlini P; Shpall E J; Qazilbash M H; Molldrem J J; Chemaly R F; Komanduri K V
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.
Bone marrow transplantation 2007;40(2):125-36.
-
2007: Jabbour Elias; Hosing Chitra; Ayers Gregory; Nunez Rodolfo; Anderlini Paolo; Pro Barbara; Khouri Issa; Younes Anas; Hagemeister Fredrick; Kwak Larry; Fayad Luis
Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.
Cancer 2007;109(12):2481-9.
-
2007: Oran Betul; Donato Michele; Aleman Ana; Hosing Chitra; Korbling Martin; Detry Michelle A; Wei Caimiao; Anderlini Paolo; Popat Uday; Shpall Elizabeth; Giralt Sergio; Champlin Richard E
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):469-77.
-
2007: Oran Betul; Giralt Sergio; Saliba Rima; Hosing Chitra; Popat Uday; Khouri Issa; Couriel Daniel; Qazilbash Muzaffar; Anderlini Paolo; Kebriaei Partow; Ghosh Shubhra; Carrasco-Yalan Antonio; de Meis Ernesto; Anagnostopoulos Athanasios; Donato Michele; Champlin Richard E; de Lima Marcos
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):454-62.
-
2006: Johnson Malisha R; Del Carpio-Jayo Daniel; Lin Pei; Giralt Sergio; Anderlini Paolo; Champlin Richard E; Khouri Issa F; Vadhan-Raj Saroj; Medeiros L Jeffrey; Bueso-Ramos Carlos E
Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
Annals of diagnostic pathology 2006;10(5):263-8.
-
2006: Lekakis L; Giralt S; Couriel D; Shpall E J; Hosing C; Khouri I F; Anderlini P; Korbling M; Martin T; Champlin R E; de Lima M
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.
Bone marrow transplantation 2006;38(6):421-6.
-
2006: Hosing Chitra; Saliba Rima M; Körbling Martin; Acholonu Sandra; McMannis John; Anderlini Paolo; Giralt Sergio; De Lima Marcos; Okoroji Grace-Julia; Couriel Daniel R; Champlin Richard; Khouri Issa F; Donato Michele L
High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2006;47(7):1290-4.
-
2006: Anderlini Paolo; Champlin Richard E
Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: where do we stand?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(6):599-602.
-
2006: Hosing Chitra; Qazilbash Muzaffar H; Kebriaei Partow; Giralt Sergio; Davis Marilyn S; Popat Uday; Anderlini Paolo; Shpall Elizabeth J; McMannis John; Körbling Martin; Champlin Richard E
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma.
British journal of haematology 2006;133(5):533-7.
-
2006: Ueno N T; Konoplev S; Buchholz T A; Smith T; Rondón G; Anderlini P; Giralt S A; Gajewski J L; Donato M L; Cristofanilli M; Champlin R E
High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy.
Bone marrow transplantation 2006;37(10):929-35.
-
2006: Couriel Daniel R; Hosing Chitra; Saliba Rima; Shpall Elizabeth J; Anderlini Paolo; Rhodes Beverly; Smith Veronica; Khouri Issa; Giralt Sergio; de Lima Marcos; Hsu Yvonne; Ghosh Shubhra; Neumann Joyce; Andersson Borje; Qazilbash Muzzafar; Hymes Sharon; Kim Stella; Champlin Richard; Donato Michele
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.
Blood 2006;107(8):3074-80.
-
2005: Anderlini P; Saliba R; Acholonu S; Okoroji G-J; Donato M; Giralt S; Andersson B; Ueno N T; Khouri I; De Lima M; Hosing C; Cohen A; Ippoliti C; Romaguera J; Rodriguez M A; Pro B; Fayad L; Goy A; Younes A; Champlin R E
Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen.
Bone marrow transplantation 2005;35(10):943-51.
-
2005: Khouri Issa F; Saliba Rima M; Hosing Chitra; Okoroji Grace-Julia; Acholonu Sandra; Anderlini Paolo; Couriel Daniel; De Lima Marcos; Donato Michele L; Fayad Luis; Giralt Segio; Jones Roy; Korbling Martin; Maadani Farzaneh; Manning John T; Pro Barbara; Shpall Elizabeth; Younes Anas; McLaughlin Peter; Champlin Richard E
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2240-7.
-
2005: Wong Raymond; Shahjahan Munir; Wang Xuemei; Thall Peter F; De Lima Marcos; Khouri Issa; Gajewski James; Alamo Jorge; Couriel Daniel; Andersson Borje S; Donato Michelle; Hosing Chitra; Komanduri Krishna; Anderlini Paolo; Molldrem Jeffrey; Ueno Naoto T; Estey Elihu; Ippoliti Cindy; Champlin Richard; Giralt Sergio
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):108-14.
-
2004: Anderlini Paolo; Sheth Sheetal; Hicks Krystal; Ippoliti Cindy; Giralt Sergio; Champlin Richard E
Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):883-4.
-
2004: Anderlini P; Acholonu S A; Okoroji G-J; Andersson B S; Couriel D R; De Lima M J; Donato M L; Khouri I F; Giralt S A; Ueno N T; Champlin R E
Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response.
Bone marrow transplantation 2004;34(6):511-4.
-
2004: Couriel Daniel; Saliba Rima; Hicks Krystal; Ippoliti Cindy; de Lima Marcos; Hosing Chitra; Khouri Issa; Andersson Borje; Gajewski James; Donato Michele; Anderlini Paolo; Kontoyiannis Dimitrios P; Cohen Agueda; Martin Thomas; Giralt Sergio; Champlin Richard
Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.
Blood 2004;104(3):649-54.
-
2004: Popat U; Hosing C; Saliba R M; Anderlini P; van Besien K; Przepiorka D; Khouri I F; Gajewski J; Claxton D; Giralt S; Rodriguez M; Romaguera J; Hagemeister F; Ha C; Cox J; Cabanillas F; Andersson B S; Champlin R E
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
Bone marrow transplantation 2004;33(10):1015-23.
-
2004: Couriel Daniel R; Saliba Rima M; Giralt Sergio; Khouri Issa; Andersson Borje; de Lima Marcos; Hosing Chitra; Anderlini Paolo; Donato Michelle; Cleary Karen; Gajewski James; Neumann Joyce; Ippoliti Cindy; Rondon Gabriela; Cohen Agueda; Champlin Richard
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):178-85.
-
2004: Khouri Issa F; Lee Ming-Sheng; Saliba Rima M; Andersson Borje; Anderlini Paolo; Couriel Daniel; Hosing Chitra; Giralt Sergio; Korbling Martin; McMannis John; Keating Michael J; Champlin Richard E
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival.
Experimental hematology 2004;32(1):28-35.
-
2003: Ueno Naoto T; Cheng Yee Chung; Rondón Gabriela; Tannir Nizar M; Gajewski James L; Couriel Daniel R; Hosing Chitra; de Lima Marcos J; Anderlini Paolo; Khouri Issa F; Booser Daniel J; Hortobagyi Gabriel N; Pagliaro Lance C; Jonasch Eric; Giralt Sergio A; Champlin Richard E
Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors.
Blood 2003;102(10):3829-36.
-
2003: Hong David S; Jacobson Kalen L; Raad Issam I; de Lima Marcos; Anderlini Paolo; Fuller Gregory N; Ippoliti Cindy; Cool Rita M; Leeds Norman E; Narvios Aida; Han Xiang Y; Padula Anthony; Champlin Richard E; Hosing Chitra
West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(8):1044-9.
-
2003: Linker Charles; Anderlini Paolo; Herzig Roger; Christiansen Neal; Somlo George; Bensinger William; Fay Joseph; Lynch Joseph P; Goodnough Lawrence T; Ashby Mark; Benyunes Mark C; Jones Dennie V; Yang Timothy A; Miller Langdon L; Weaver Charles
Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(6):405-13.
-
2003: Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Bone marrow transplantation 2003;31(6):459-65.
-
2003: Champlin Richard; Khouri Issa; Anderlini Paolo; De Lima Marcos; Hosing Chitra; McMannis John; Molldrem Jeffrey; Ueno Naoto; Giralt Sergio
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.
Oncology (Williston Park, N.Y.) 2003;17(1):94-100; discussion 103-7.
-
2002: Anderlini P; Chan F A; Champlin R E; Körbling M; Strom S S
Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development.
Bone marrow transplantation 2002;30(10):661-3.
-
2002: Han X Y; Anderlini P; Tarrand J
Diagnosis and monitoring of primary cytomegalovirus infection by antigenemia test.
Bone marrow transplantation 2002;30(6):411.
-
2002: Giralt S; Aleman A; Anagnostopoulos A; Weber D; Khouri I; Anderlini P; Molldrem J; Ueno N T; Donato M; Korbling M; Gajewski J; Alexanian R; Champlin R
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.
Bone marrow transplantation 2002;30(6):367-73.
-
2002: Esmaeli Bita; Ahmadi M Amir; Kim Stella; Onan Hillary; Korbling Martin; Anderlini Paolo
Marginal keratitis associated with administration of filgrastim and sargramostim in a healthy peripheral blood progenitor cell donor.
Cornea 2002;21(6):621-2.
-
2002: Kim Rosa Y; Anderlini Paolo; Naderi Aresu A; Rivera Pettion; Ahmadi M Amir; Esmaeli Bita
Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation.
American journal of ophthalmology 2002;133(6):843-5.
-
2002: Anderlini Paolo; Champlin Richard
Use of filgrastim for stem cell mobilisation and transplantation in high-dose cancer chemotherapy.
Drugs 2002;62 Suppl 1():79-88.
-
2002: Gajewski James L; Rondon Gabriela; Donato Michele L; Anderlini Paolo; Korbling Martin; Ippoliti Cindy; Benyunes Mark; Miller Langdon L; LaTemple Denise; Jones Denny; Ashby Mark; Hellmann Sue; Durett April; Lauppe Jo; Geisler Deborah; Khouri Issa F; Giralt Sergio A; Andersson Borje; Ueno Naoto T; Champlin Richard
Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(10):550-6.
-
2002: Andersson Borje S; Thall Peter F; Madden Timothy; Couriel Daniel; Wang Xuemei; Tran Hai T; Anderlini Paolo; de Lima Marcos; Gajewski James; Champlin Richard E
Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(9):477-85.
-
2001: Khouri I F; Saliba R M; Giralt S A; Lee M S; Okoroji G J; Hagemeister F B; Korbling M; Younes A; Ippoliti C; Gajewski J L; McLaughlin P; Anderlini P; Donato M L; Cabanillas F F; Champlin R E
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
Blood 2001;98(13):3595-9.
-
2001: Körbling M; Anderlini P
Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?
Blood 2001;98(10):2900-8.
-
2001: Przepiorka D; Anderlini P; Saliba R; Cleary K; Mehra R; Khouri I; Huh Y O; Giralt S; Braunschweig I; van Besien K; Champlin R
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation.
Blood 2001;98(6):1695-700.
-
2001: Ghosh S; Champlin R E; Ueno N T; Anderlini P; Rolston K; Raad I; Kontoyiannis D; Jacobson K; Luna M; Tarrand J; Whimbey E
Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins.
Bone marrow transplantation 2001;28(3):271-5.
-
2001: Bibawi S; Abi-Said D; Fayad L; Anderlini P; Ueno N T; Mehra R; Khouri I; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Andreeff M; Andersson B S; Estey E H; Champlin R; Przepiorka D
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
American journal of hematology 2001;67(4):227-33.
-
2001: Giles F J; Shen Y; Kantarjian H M; Korbling M J; O'Brien S; Anderlini P; Donato M; Pierce S; Keating M J; Freireich E J; Estey E
Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survival.
Leukemia & lymphoma 2001;42(1-2):67-73.
-
2001: Ravandi F; Kantarjian H; Cohen A; Davis M; O'Brien S; Anderlini P; Andersson B; Claxton D; Donato M; Gajewski J; Khouri I; Korbling M; Ueno N; deVos D; Champlin R; Giralt S
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study.
Bone marrow transplantation 2001;27(12):1221-5.
-
2001: Przepiorka D; Smith T L; Folloder J; Anderlini P; Chan K W; Körbling M; Lichtiger B; Norfleet F; Champlin R
Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors.
Blood 2001;97(11):3405-10.
-
2001: Champlin R; Khouri I; Anderlini P; Gajewski J; Kornblau S; Molldrem J; Shimoni A; Ueno N; Giralt S
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation.
Bone marrow transplantation 2001;27 Suppl 2():S13-22.
-
2001: Shimoni A; Smith T L; Aleman A; Weber D; Dimopoulos M; Anderlini P; Andersson B; Claxton D; Ueno N T; Khouri I; Donato M; Korbling M; Alexanian R; Champlin R; Giralt S
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma.
Bone marrow transplantation 2001;27(8):821-8.
-
2001: Anderlini P; Rizzo J D; Nugent M L; Schmitz N; Champlin R E; Horowitz M M;
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases.
Bone marrow transplantation 2001;27(7):689-92.
-
2001: Giralt S; Thall P F; Khouri I; Wang X; Braunschweig I; Ippolitti C; Claxton D; Donato M; Bruton J; Cohen A; Davis M; Andersson B S; Anderlini P; Gajewski J; Kornblau S; Andreeff M; Przepiorka D; Ueno N T; Molldrem J; Champlin R
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.
Blood 2001;97(3):631-7.
-
2001: Körbling M; Giralt S; Khouri I; Mirza N; Donato M; Anderlini P; Fischer H; Andreeff M; McMannis J; Champlin R
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis.
Journal of clinical apheresis 2001;16(2):82-7.
-
2000: Champlin R; Khouri I; Shimoni A; Gajewski J; Kornblau S; Molldrem J; Ueno N; Giralt S; Anderlini P
Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.
British journal of haematology 2000;111(1):18-29.
-
2000: Anderlini P; Giralt S; Andersson B; Ueno N T; Khouri I; Acholonu S; Cohen A; Körbling M J; Manning J; Romaguera J; Sarris A; Rodriguez; Hagemeister F; Mclaughlin P; Cabanillas F; Champlin R E
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease.
Bone marrow transplantation 2000;26(6):615-20.
-
2000: Anderlini P; Donato M; Lauppe M J; Huh Y O; Martin T G; Chan K W; Champlin R E; Körbling M
A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors.
British journal of haematology 2000;109(4):770-2.
-
2000: Donato M L; Gershenson D; Ippoliti C; Wharton J T; Bast R C; Aleman A; Anderlini P; Gajewski J G; Giralt S; Molldrem J; Ueno N; Lauppe J; Korbling M; Boyer J; Bodurka-Bevers D; Bevers M; Burke T; Freedman R; Levenback C; Wolf J; Champlin R E
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer.
Bone marrow transplantation 2000;25(11):1137-40.
-
2000: Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri I F; Folloder J; Ueno N T; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson B S; Champlin R
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(2A):190-7.
-
1999: Khouri I F; Lee M S; Romaguera J; Mirza N; Kantarjian H; Korbling M; Albitar M; Giralt S; Samuels B; Anderlini P; Rodriguez J; von Wolff B; Gajewski J; Cabanillas F; Champlin R
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1293-9.
-
1999: Donato M L; Champlin R E; Van Besien K W; Korbling M; Cabanillas F; Anderlini P; Gajewski J G; Lauppe J; Durett A; Andersson B; Giralt S; Khouri I; Hagemeister F; Romaguera J E; Sarris A; McLaughlin P; Younes A; Ippoliti C; Blamble D A; Hester J; Gee A; Rodriguez M A
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 1999;35(3-4):317-24.
-
1999: Champlin R; Khouri I; Kornblau S; Marini F; Anderlini P; Ueno N T; Molldrem J; Giralt S
Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy.
Hematology/oncology clinics of North America 1999;13(5):1041-57, vii-viii.
-
1999: Przepiorka D; Khouri I; Ippoliti C; Ueno N T; Mehra R; Körbling M; Giralt S; Gajewski J; Fischer H; Donato M; Cleary K; Claxton D; Chan K W; Braunschweig I; van Besien K; Andersson B S; Anderlini P; Champlin R
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.
Bone marrow transplantation 1999;24(7):763-8.
-
1999: Przepiorka D; Smith T L; Folloder J; Khouri I; Ueno N T; Mehra R; Körbling M; Huh Y O; Giralt S; Gajewski J; Donato M; Cleary K; Claxton D; Braunschweig I; van Besien K; Andersson B S; Anderlini P; Champlin R
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation.
Blood 1999;94(4):1465-70.
-
1999: Anderlini P; Riggs S A; Körbling M; Champlin R
Syngeneic blood stem cell transplantation for infectious mononucleosis-related aplastic anaemia.
British journal of haematology 1999;106(1):159-61.
-
1999: Anderlini P; Donato M; Chan K W; Huh Y O; Gee A P; Lauppe M J; Champlin R E; Körbling M
Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience.
Transfusion 1999;39(6):555-60.
-
1999: Przepiorka D; van Besien K; Khouri I; Hagemeister F; Samuels B; Folloder J; Ueno N T; Molldrem J; Mehra R; Körbling M; Giralt S; Gajewski J; Donato M; Cleary K; Claxton D; Braunschweig I; Andersson B; Anderlini P; Champlin R
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):527-32.
-
1999: Przepiorka D; Lu J G; Anderlini P; Körbling M; Donato M; Champlin R; Gee A P; van Vlasselaer P
Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel system.
Cytotherapy 1999;1(2):111-7.
-
1998: Khouri I F; Keating M; Körbling M; Przepiorka D; Anderlini P; O'Brien S; Giralt S; Ippoliti C; von Wolff B; Gajewski J; Donato M; Claxton D; Ueno N; Andersson B; Gee A; Champlin R
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2817-24.
-
1998: Anderlini P; Przepiorka D; Körbling M; Champlin R
Blood stem cell procurement: donor safety issues.
Bone marrow transplantation 1998;21 Suppl 3():S35-9.
-
1998: Ueno N T; Rondón G; Mirza N Q; Geisler D K; Anderlini P; Giralt S A; Andersson B S; Claxton D F; Gajewski J L; Khouri I F; Körbling M; Mehra R C; Przepiorka D; Rahman Z; Samuels B I; van Besien K; Hortobagyi G N; Champlin R E
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):986-93.
-
1998: Popat U; Przepiork D; Champlin R; Pugh W; Amin K; Mehra R; Rodriguez J; Giralt S; Romaguera J; Rodriguez A; Preti A; Andersson B; Khouri I; Claxton D; de Lima M; Donato M; Anderlini P; Gajewski J; Cabanillas F; van Besien K
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):63-9.
-
1997: van Besien K; Thall P; Korbling M; Pugh W C; Khouri I; Mehra R; Giralt S; Anderlini P; Amin K; Mirza N; Seong D; Gajewski J; Hester J; Andersson B; Cabanillas F; Champlin R; Przepiorka D
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(3):150-6.
-
1997: Giralt S; Estey E; Albitar M; van Besien K; Rondón G; Anderlini P; O'Brien S; Khouri I; Gajewski J; Mehra R; Claxton D; Andersson B; Beran M; Przepiorka D; Koller C; Kornblau S; Kørbling M; Keating M; Kantarjian H; Champlin R
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
Blood 1997;89(12):4531-6.
-
1997: Anderlini P; Przepiorka D; Lauppe J; Seong D; Giralt S; Champlin R; Körbling M
Collection of peripheral blood stem cells from normal donors 60 years of age or older.
British journal of haematology 1997;97(2):485-7.
-
1997: Anderlini P; Przepiorka D; Seong C; Smith T L; Huh Y O; Lauppe J; Champlin R; Körbling M
Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim.
Transfusion 1997;37(5):507-12.
-
1997: Seong C; Durett A; Mirza N; Huh Y; Anderlini P; Champlin R
Mobilization kinetics of CD34+/Thy-1dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors.
Transfusion 1997;37(4):406-10.
-
1997: Przepiorka D; Anderlini P; Ippoliti C; Khouri I; Fietz T; Thall P; Mehra R; Giralt S; Gajewski J; Deisseroth A B; Cleary K; Champlin R; van Besien K; Andersson B; Körbling M
Allogeneic blood stem cell transplantation in advanced hematologic cancers.
Bone marrow transplantation 1997;19(5):455-60.
-
1997: Anderlini P; Lauppe J; Przepiorka D; Seong D; Champlin R; Körbling M
Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections.
British journal of haematology 1997;96(2):415-7.
-
1996: Przepiorka D; Ippoliti C; Khouri I; Anderlini P; Mehra R; Giralt S; Gajewski J; Fritsche H; Deisseroth A B; Cleary K; Champlin R; van Besien K; Andersson B; Korbling M
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus.
Transplantation 1996;62(12):1806-10.
-
1996: Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
Bone marrow transplantation 1996;18(6):1073-9.
-
1996: Körbling M; Chan K W; Anderlini P; Seong D; Durett A; Langlinais A; Przepiorka D; Gajewski J; Miller P; Sundberg J; Alilaen P; Bojko P; Mirza N; Claxton D; van Besien K; Khouri I; Andersson B; Mehra R; Champlin R
Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors.
Bone marrow transplantation 1996;18(5):885-90.
-
1996: Anderlini P; Przepiorka D; Champlin R; Körbling M
Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals.
Blood 1996;88(8):2819-25.
-
1996: Anderlini P; Przepiorka D; Seong D; Champlin R; Körbling M
Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis.
British journal of haematology 1996;94(1):155-8.
-
1996: Anderlini P; Przepiorka D; Seong D; Miller P; Sundberg J; Lichtiger B; Norfleet F; Chan K W; Champlin R; Körbling M
Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures.
Transfusion 1996;36(7):590-5.
-
1996: Anderlini P; Przepiorka D; Huh Y; Lauppe J; Miller P; Sundberg J; Seong D; Champlin R; Körbling M
Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation.
British journal of haematology 1996;93(4):940-2.
-
1996: Anderlini P; Ghaddar H M; Smith T L; Pierce S; Kantarjian H M; O'Brien S; Keating M J; Freireich E J; Estey E H
Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(6):964-9.
-
1996: Anderlini P; Luna M; Kantarjian H M; O'Brien S; Pierce S; Keating M J; Estey E H
Causes of initial remission induction failure in patients with acute myeloid leukemia and myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(4):600-8.
-
1996: Kantarjian H M; O'Brien S; Anderlini P; Talpaz M
Treatment of myelogenous leukemia: current status and investigational options.
Blood 1996;87(8):3069-81.
-
1995: Anderlini P; Benjamin R S; Wong F C; Kantarjian H M; Andreeff M; Kornblau S M; O'Brien S; Mackay B; Ewer M S; Pierce S A
Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2827-34.
-
1995: Körbling M; Huh Y O; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth A B; Champlin R E
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
Blood 1995;86(7):2842-8.
-
1995: Anderlini P; Buzaid A C; Legha S S
Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanoma.
Cancer 1995;76(4):678-9.
-
1994: Anderlini P; Przepiorka D; Luna M; Langford L; Andreeff M; Claxton D; Deisseroth A B
Acanthamoeba meningoencephalitis after bone marrow transplantation.
Bone marrow transplantation 1994;14(3):459-61.
Sign-in to see more
